朝觐期间脑膜炎奈瑟菌鼻咽部携带状况:评估环丙沙星预防必要性的队列研究
该前瞻性配对与非配对队列研究在朝觐开始和结束时采集朝觐者鼻咽样本,评估脑膜炎奈瑟菌携带率变化及疫苗接种依从性。结果显示配对队列中抵达时携带率为5.7%,朝觐后为2.5%,以B血清群为主;作者认为应重新考虑继续使用环丙沙星作为预防性抗生素,并考虑将B血清群纳入 required vaccination。
要点
- 配对队列628人中,抵达时36人(5.7%)脑膜炎奈瑟菌阳性,朝觐后16人(2.5%)阳性。
- 非配对抵达队列1055人中36人(3.4%)阳性,其中24人(66.7%)为B血清群。
- 所有朝觐者均接种脑膜炎疫苗,98.2%接种四价多糖疫苗,1.8%接种MCV4。
核心结论
- 这是朝觐者中脑膜炎奈瑟菌流行病学最大的研究,显示来自高地方性流行区的朝觐者与其他朝觐者之间携带率存在显著差异,以B血清群为主。
- 作者认为应重新考虑继续使用环丙沙星作为预防性抗生素,并考虑将B血清群纳入 required vaccination。
研究设计与样本
- 前瞻性配对(抵达和离开)及非配对抵达、非配对离开队列研究,在朝觐开始和结束时采集鼻咽样本。
- 研究纳入阿卜杜勒阿齐兹国王国际机场非配对抵达朝觐者1055人、非配对离开队列373人、配对队列628人(抵达和离开时均检测)。
主要发现
- 所有朝觐者均接种脑膜炎疫苗,98.2%接种四价多糖疫苗(ACWY),1.8%接种脑膜炎四价结合疫苗(MCV4)。
- 仅1.61%和23.03%分别接种肺炎球菌疫苗和流感疫苗。
- 非配对抵达朝觐者1055人中,36人(3.4%)鼻咽部脑膜炎奈瑟菌携带阳性,其中24人(66.7%)为B血清群,其余为不可分群。
- 检出流感嗜血杆菌45人(4.3%),11名(1%)携带者同时阳性 for 脑膜炎奈瑟菌和流感嗜血杆菌。
- 非配对离开队列373人中,6人(1.61%)脑膜炎奈瑟菌阳性,34人(9.1%)流感嗜血杆菌阳性;配对队列628人中,抵达时36人(5.7%)阳性,朝觐后16人(2.5%)阳性。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The annual Muslim pilgrimage has the potential of increase risk for acquisition of Neisseria meningitidis. Here, we evaluate the Hajj impact on the prevalence of N. meningitidis carriage in a paired and non-paired cohort of pilgrims. Secondary objectives were to calculate the compliance with recommended vaccination. METHODS: This is a prospective paired (arriving and departing), non-paired arriving and non-paired departing cohort study with the collection of nasopharyngeal samples at the start and the end of the Hajj. RESULTS: The study included unpaired arriving pilgrims at King Abdul Aziz International Airport (N=1055), unpaired departing cohort (N=373), and a paired cohort (N=628) who were tested on arrival and departure. Meningococcal vaccination was received by all pilgrims, 98.2% received quadrivalent polysaccharide vaccine (ACWY), and 1.8% received meningococcal quadrivalent conjugate vaccine (MCV4). Only 1.61% and 23.03% received pneumococcal and influenza vaccines, respectively. Of the 1055 arriving unpaired pilgrim, 36 (3.4%) tested positive for nasopharyngeal carriage of N. meningitidis, and 24 (66.7%) of these were serogroup B, the remainder were non-groupable. Haemophilus influenza was detected among 45 (4.3%), and 11 (1%) carriers were positive for both N. meningitidis and H. influenzae. Out of 373 in the unpaired departing cohort, 6 (1.61%) tested positive for N. meningitidis, and 34 (9.1%) were positive for H. influenzae. Of the 628 paired cohort pilgrims, 36 (5.7%) pilgrims were positive for N. meningitidis at arrival and 16 (2.5%) pilgrims were positive after the hajj. CONCLUSION: This the largest study of the epidemiology of N. meningitidis among pilgrims. The study showed a significant difference in the carriage between pilgrims from high endemicity and other pilgrims with a predominance of serogroup B. The continued use of ciprofloxacin as prophylactic antibiotics should be reconsidered as well as the consideration to add serogroup B as a required vaccination.
引用
- Memish ZA, Al-Tawfiq JA, Almasri M, et al. Neisseria meningitidis nasopharyngeal carriage during the Hajj: A cohort study evaluating the need for ciprofloxacin prophylaxis. Vaccine. 2017. PMID: 28343777. doi:10.1016/j.vaccine.2017.03.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。